Issue Date | Title | Author(s) |
2011-12-01 | Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice | Tan, Y; Sun, LQ; Kamal, MA; Wang, X; Seale, JP; Qu, X |
2016-08-26 | Characterisation of Bone Beneficial Components from Australian Wallaby Bone. | Lao, W; Jin, X; Tan, Y; Xiao, L; Padula, MP; Bishop, DP; Reedy, B; Ong, M; Kamal, MA; Qu, X |
2009-12-01 | Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease | Kamal, MA; Tan, Y; Seale, JP; Qu, X |
- | Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma | Allam, VSRR; Paudel, KR; Gupta, G; Singh, SK; Vishwas, S; Gulati, M; Gupta, S; Chaitanya, MVNL; Jha, NK; Gupta, PK; Patel, VK; Liu, G; Kamal, MA; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
2017-01-01 | Inhibition of butyrylcholinesterase with fluorobenzylcymserine, an experimental Alzheimer’s drug candidate: Validation of enzoinformatics results by classical and innovative enzyme kinetic analyses | Kamal, MA; Shakil, S; Nawaz, MS; Yu, QS; Tweedie, D; Tan, Y; Qu, X; Greig, NH |
2011-04-01 | Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome | Tan, Y; Kamal, MA; Wang, ZZ; Xiao, W; Seale, JP; Qu, X |
2020-12-09 | Antrodia cinnamomea Inhibits Growth and Migration of Lung Cancer Cells through Regulating p53-Bcl2 and MMPs Pathways. | Tan, Y; Johnson, M; Zhou, J; Zhao, Y; Kamal, MA; Qu, X |
2013-01 | Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats. | Tan, Y; Lao, W; Xiao, L; Wang, Z; Xiao, W; Kamal, MA; Seale, JP; Qu, X |
2008-06-01 | Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis | Kamal, MA; Qu, X; Yu, QS; Tweedie, D; Holloway, HW; Li, Y; Tan, Y; Greig, NH |